Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Gds Stock Analysis Gds Holdings Limited Ads 4.2 Drop Data Center Support Level Check 20260403 APH Amphenol notches 29 percent Q4 2025 EPS beat dips slightly as investors react tepidly What Wall Street expects from Relmada Therapeutics RLMD this quarter Relmada Therapeutics posts 103 negative EPS miss The real value proposition of Creative CMCT stock Spikes 20260506 The quiet positioning of Westport WPRT nobody discusses At Lows 20260506 Anthropic and Gates Foundation Forge 200 Million AI Partnership to Transform Health Education and Agriculture OPAL Fuels OPAL Q1 2026 Results Fall Short EPS 009 Revenue NA The PNTG Stock Steady at 3540 Support at 3363 20260519 HIVE Shares Surge as BUZZ HPC Launches 320 MW AI Data Center Near Toronto Portugals Meo Sues State for 82 Million Over Huawei 5G Ban SP Global SPGI Dividend Appeal Highlighted as Mobility SpinOff Approaches DOE Highlights Advancements in PlugIn Electric Vehicles and Battery Technology Wall Street Ends Mixed Oil Prices Slide on Iran Deal Hopes Micron Gains 56 GlobalFoundries Drops 9 Markets React Optimistically as Iran Nuclear Talks Progress Amid Diplomatic Doubts OFS Q1 2026 Earnings Staggering EPS Beat of 475 Surprises Market BBVA Q1 2026 Earnings Earnings Beat Fails to Lift Shares as Revenue Remains Undisclosed Airship AI Holdings Inc AISP Q3 2025 Earnings Significant EPS Miss Amidst Lack of Revenue Disclosure GASS Q4 2025 Earnings EPS Beat of 417 Highlights Operational Efficiency Amid Market Headwinds EXK Q1 2026 Earnings EPS Surges Past Estimates by Nearly 60 Yet Shares Dip Haemonetics HAE Rises 116 as Shares Approach Resistance Level Urban Edge Properties UE Posts Slight Gain as Stock Holds Above Support Level Commercial Bancgroup Inc CBK Slides 138 as Selling Pressure Tests Key Support Magic Empire Global Limited MEGL Struggles Near Support as Selling Pressure Persists OKYO Pharma Shares Edge Higher as Biotech Momentum Builds